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e examined the role of regulatory myosin light
chain (MLC) phosphorylation of myosin II in cell
migration of ﬁbroblasts. Myosin light chain kinase
(MLCK) inhibition blocked MLC phosphorylation at the cell
periphery, but not in the center. MLCK-inhibited cells did not
assemble zyxin-containing adhesions at the periphery, but
maintained focal adhesions in the center. They generated
membrane protrusions all around the cell, turned more
 
frequently, and migrated less effectively. In contrast,
Rho-associated kinase (ROCK) inhibition blocked MLC
phosphorylation in the center, but not at the periphery.
W
 
ROCK-inhibited cells assembled zyxin-containing adhesions
at the periphery, but not focal adhesions in the center. They
moved faster and more straight. On the other hand, inhibition
of myosin phosphatase increased MLC phosphorylation
and blocked peripheral membrane rufﬂing, as well as
turnover of focal adhesions and cell migration. Our results
suggest that myosin II activated by MLCK at the cell periphery
controls membrane rufﬂing, and that the spatial regulation
of MLC phosphorylation plays critical roles in controlling
cell migration of ﬁbroblasts.
 
Introduction
 
Cell migration is critical for a variety of biological processes
in normal and pathological conditions including cellular
development, tissue repair, and cancer metastasis. It is a
complex process involving a variety of cytoskeletal constituents
(Lauffenburger and Horwitz, 1996; Mitchison and Cramer,
1996; Ridley, 2001). The first step of cell migration is the
generation of a membrane protrusion in the direction of
movement. This process is driven by actin polymerization
(Pollard et al., 2000), and may also require the addition of
new membrane at the protrusion site. The second step is
the establishment of new adhesion sites in the extended
 
membrane. Motile cells assemble transient adhesions at the
leading edge, called focal complexes (Nobes and Hall,
1995). In fibroblasts, focal complexes mature into more stable
adhesions called focal adhesions (Rottner et al., 1999). Finally,
a contractile force drives the cell body forward, and the rear
part of the cell is detached from the substrate.
Myosin II is believed to be involved in the generation of
the contractile force for cell migration. The activity of
myosin II is mainly controlled by its light chain (MLC)
phosphorylation, which is regulated by two classes of enzymes,
MLC kinases and myosin phosphatase (Hartshorne et al.,
1998; Kamm and Stull, 2001; Somlyo and Somlyo, 2003).
Myosin light chain kinase (MLCK) and ROCK/ROK/Rho
kinase (called ROCK in this paper) appear to be two major
kinases that phosphorylate MLC in vitro as well as in vivo.
Other kinases including DAPK (Jin et al., 2001), PAK
(Chew et al., 1998), ZIP-kinase (Murata-Hori et al., 1999),
and citron kinase (Yamashiro et al., 2003) have been reported
to phosphorylate MLC, although the physiological signifi-
cance is yet to be established. Myosin phosphatase consists
of a catalytic subunit of PP1c-delta, a large subunit termed
the myosin phosphatase targeting subunit (MYPT, also
called MBS or M130) and a 20-kD small subunit (Alessi et
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al., 1992). MYPT is a major regulator of myosin phosphatase
activity because it binds both PP1c and the substrate, phos-
phorylated myosin II, thus targeting the substrate to the cata-
lytic subunit. MYPT is phosphorylated by a number of ki-
nases including ROCK/ROK/Rho-kinase (Kimura et al.,
1996), ZIP-like kinase (MacDonald et al., 2001), integrin-
linked kinase (Kiss et al., 2002), myotonic dystrophy protein
kinase (Muranyi et al., 2001), and PAK (Takizawa et al.,
2002), which results in the inhibition of myosin phosphatase
activity. Involvement of other kinases including PKA (Ito et
al., 1997), PKG (Surks et al., 1999), and an unidentified mi-
totic kinase (Totsukawa et al., 1999) in the regulation of my-
osin phosphatase activity are also suggested.
It is generally accepted that myosin II plays a role in the
last step of cell migration, i.e., the translocation of cell body
forward by the contraction of the posterior region (Lauffen-
burger and Horwitz, 1996; Mitchison and Cramer, 1996).
This notion is supported by the localization of phosphory-
lated myosin II at the rear of migrating cells (Post et al.,
1995; Matsumura et al., 1998). However, myosin II is likely
to play additional and more complex roles in cell migration.
Using a specific antibody against phosphorylated MLC, we
observed that phosphorylated myosin II is also localized in
the anterior regions of motile fibroblasts (Matsumura et al.,
1998). Although this observation suggests a role of myosin
II other than in rear contraction, little is known about the
role of MLC phosphorylation in cell migration at the pe-
riphery of the cell.
Using a newly-developed inhibitor of MLCK (Wu et al.,
2003) and a well-established inhibitor of ROCK (Uehata et
al., 1997), we have been able to block MLC phosphoryla-
tion specifically at the periphery and at the cell center, re-
spectively. We found that the spatially-differentiated reduc-
tion of MLC phosphorylation produced strikingly opposing
effects on the cell migration, as well as on membrane protru-
sions and the dynamics of focal adhesions of free-moving fi-
broblasts. Our results indicate new localization-specific roles
of phosphorylated myosin II in the regulation of membrane
protrusions and cell migration.
 
Results
 
Inhibition of MLCK induces multiple membrane 
protrusions, whereas inhibition of ROCK restricts 
membrane protrusions mostly to one site
 
We examined how the inhibition of MLCK or ROCK af-
fects cell migration of free-moving fibroblasts. To block
MLCK, we used a new, membrane-permeable biotin-TAT
inhibitor (BATI; see Materials and methods). To block
ROCK, we used Y-27632, a specific inhibitor of ROCK.
Gerbil fibroma cells were treated with each inhibitor for
30 min, and then cell migration was examined by phase-
contrast, time-lapse microscopy (see Videos 1–4, available at
http://www.jcb.org/cgi/content/full/jcb.200306172/DC1).
Fig. 1 A depicts the images taken at 0 and 60 min from the
time-lapse movies (a and b for control; d and e for MLCK-
inhibited; g and h for ROCK-inhibited; j and k for both
MLCK- and ROCK-inhibited cells). To show net cell trans-
location, the geographical centers of each cell at 0 (shown in
red) and 60 min (black) were determined, and the distance
of migration was shown in c, f, i, and l by connecting two
centers. This analysis shows that the inhibition of MLCK re-
duced net translocation (f). In contrast, the inhibition of
ROCK increased translocation of the geographical center (i),
though long tails, a characteristic morphology induced by
Figure 1. Effects of MLCK and ROCK inhibitors on cell migration, 
membrane protrusions, and cell morphology. (A) Phase-contrast, 
time-lapse video microscopy. The left and middle panels of each row 
show the images at 0 and 60 min, respectively. The right panels 
of each row show the net translocation (see Results for details). 
Bar, 20  m. (B) Multiple protrusions (arrowheads) shown by MLCK-
inhibited cells. The time-lapse images at 0, 20, 40, and 60 min corre-
spond to the rectangular portion of A (d). (C) Cell spreading and 
polarity. Areas of cells and ratios of major and minor axis were 
measured to determine cell spreading and polarity. *, P   0.05; 
**, P   0.01 as compared with control, t test. (D) Kymograph analyses 
of membrane protrusions. Red lines (1 pixel wide, 100 pixels long) 
indicated in A were used for kymograph analyses. At least eight 
kymograph analyses were performed for each condition. See also 
Videos 1–4, available at http://www.jcb.org/cgi/content/full/
jcb.200306172/DC1. 
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ROCK inhibition, often remained tethered to the substrate.
When both MLCK and ROCK were inhibited, net translo-
cation was similar to that of control cells (compare c with l).
The MLCK and ROCK inhibitors yielded very different
effects on cellular morphology, as well as on cell polarity. Al-
though many control cells (Fig. 1 A, a and b; see Video 1)
showed polarized morphology with one or two membrane
protrusions, MLCK-inhibited cells (Fig. 1 A, d and e; see
Video 2) exhibited multiple and broad protrusions all
around the cells, resulting in a more spread morphology
than control. These protrusions extended and retracted fre-
quently, as shown in Fig. 1 B (arrowheads). In contrast,
ROCK-inhibited cells showed one major protrusion and a
polarized morphology (Fig. 1 A, g and h; see Video 3).
These differences in cell spreading and polarity were con-
firmed by measurements of cell areas and the ratios of long
and short axes, respectively (Fig. 1 C). The average area of
MLCK-inhibited cells was 91% larger (
 
n
 
 
 
  
 
26) than that of
control cells (
 
n
 
 
 
 
 
 64; P
 
 
 
 
 
 0.01, 
 
t
 
 test), whereas the area
of ROCK-inhibited cells (
 
n
 
 
 
  
 
23) was very similar to that of
control. The area of MLCK- and ROCK-inhibited (
 
n
 
 
 
  
 
29)
cells was 30% larger than control (P
 
 
 
  
 
0.05, 
 
t
 
 test). The
measurement of cell polarity revealed that ROCK inhibition
increased the average ratio by 38% (P 
 
  
 
0.01, 
 
t
 
 test),
whereas MLCK inhibition reduced it by 23% (P 
 
  
 
0.05, 
 
t
 
test). The ratio of MLCK- and ROCK-inhibited cells was
similar to that of control cells.
Kymograph analyses were performed to examine the effect
of MLCK or ROCK inhibition on activity of protrusive
membranes (Fig. 1 D). In control cells, the edge of the pro-
trusive membrane was rough, and the phase density of the
edge fluctuated greatly, indicating that membranes were dy-
namically extending and retracting. During the 60-min pe-
riod, the edge in most control cells moved forward. When
MLCK was inhibited, the edge of the membrane was
smooth and the phase density of the edge remained rela-
tively low, indicating that membranes did not show cycles of
extension and retraction. The movement of the edge was re-
versed every 10–20 min, resulting in little net translocation
of the edge. In contrast, the phase density of the edge of
ROCK-inhibited cells is higher than that of MLCK-inhib-
ited cells, but lower than that of control, suggesting that
membrane ruffling occurred to a lesser extent than that of
control. Most notably, the edge moved forward more consis-
tently and faster than control cells. When both MLCK and
ROCK were inhibited, the speed and consistency of forward
movement of the membrane edge were similar to those of
control cells. However, the phase density of the edge indi-
cates that membrane activity was between those of ROCK-
and MLCK-inhibited cells.
 
MLCK-inhibited cells induced more turns in cell 
migration, whereas ROCK-inhibited cells moved 
faster and more straight
 
To examine in detail the effects of these inhibitors on cell
migration, we traced the tracks of migration shown by con-
trol, MLCK-inhibited, ROCK-inhibited, and MLCK- and
ROCK-inhibited cells (Fig. 2 A). The analyses clearly dem-
onstrated that MLCK-inhibited cells (top right) showed
much shorter net translocation than did control cells (top
left). This effect is specific to MLCK inhibition because a
peptide containing the TAT vector sequence alone (without
the pseudosubstrate sequence of MLCK) showed no effects
on cell migration (Fig. S1, available at http://www.jcb.
org/cgi/content/full/jcb.200306172/DC1). In contrast to
MLCK-inhibited cells, ROCK-inhibited cells (bottom left)
traveled much longer distances than did control cells. When
both MLCK and ROCK were inhibited (bottom right), the
tracks were similar to those of control cells.
The analyses appear to show that MLCK-inhibited cells
made turns much more frequently, whereas ROCK-inhib-
ited cells migrated more straight. To confirm this notion, we
measured absolute turn angles of trajectory of each segment
in these tracks, which is shown in Fig. 2 B as semi-circular
histograms. For comparison, the angular distribution of
control cells is shown in the right-hand side of each panel.
This analysis clearly indicates that MLCK-inhibited cells
showed evenly distributed turn angles resulting in random
movement (left). In contrast, ROCK-inhibited cells showed
more directional migration (middle). When both MLCK
and ROCK were inhibited (right), the angular distribution
was similar to that of control cells.
Fig. 2 C shows the rates of cell migration, as well as the
distances of net translocation during 60-min time periods
and directional persistence. These analyses revealed that
ROCK-inhibited cells migrated at a considerably higher rate
(0.44 
 
 
 
 0.09 
 
 
 
m/min) than did control cells (0.31 
 
 
 
 0.04
 
 
 
m/min; P
 
 
 
  
 
0.01, 
 
t
 
 test). The higher rate, as well as the
lower frequency of turns (Fig. 2 B), explains why ROCK-
inhibited cells traveled nearly three times the distance (20.8 
 
 
 
5.9 
 
 
 
m) than did control cells (7.6 
 
 
 
 2.6 
 
 
 
m), and showed
the highest directional persistence (0.83 
 
 
 
 0.14). On the
other hand, the net translocation of MLCK-inhibited cells
(3.3 
 
 
 
 1.4 
 
 
 
m) was significantly lower (34%) than that of
control cells (P
 
 
 
  
 
0.01, 
 
t
 
 test), whereas the rate of migration
was statistically similar to that of control cells (0.31 
 
 
 
 0.08
 
 
 
m/min). Consistent with these analyses, the directional
persistence of MLCK-inhibited cells (0.18 
 
 
 
 0.08) was
much lower than that of control cells (0.52 
 
 
 
 0.10). The in-
hibition of cell migration by MLCK inhibition is consistent
with previous reports that the inactivation of MLCK re-
sulted in the cessation of cell motility of eosinophil and neu-
trophil cells (Walker et al., 1998; Eddy et al., 2000). When
both were inhibited, the rate (0.34 
 
 
 
 0.06 
 
 
 
m/min), as well
as the net translocation (8.6 
 
 
 
 5.2 
 
 
 
m) and the directional
persistence (0.43 
 
 
 
 0.21), appear to be similar to those val-
ues of control cells.
 
Differential roles of MLCK and ROCK in the spatial 
regulation of MLC phosphorylation, actin organization, 
and assembly of focal adhesions
 
To address the mechanisms by which the inhibition of
MLCK and ROCK exerts distinct effects on cell migration
and cellular polarity, we examined, by ratio imaging, how
these inhibitors alter spatial distribution of MLC phos-
phorylation (Fig. 3 A), and then analyzed how such alter-
ations affect the assembly of focal adhesions and actin or-
ganization (Fig. 3 B). For ratio imaging (Fig. 3 A), cells
were double stained with an antibody against the heavy
chain of myosin (myosin HC; a, d, g, and j) and anti-phos- 
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phorylated MLC antibody (P-MLC; b, e, h, and k). Then,
ratio images of phosphorylated MLC/total myosin (c, f, i,
and l) were generated using IPLab image analysis software
(Scanalytics). To examine the organization of focal adhe-
sions and the actin cytoskeleton (Fig. 3 B), cells were triple
stained with antibodies against phosphorylated MLC (a, d,
g, and j) and vinculin (b, e, h, and k), and with fluorescent
phalloidin (c, f, i, and l).
MLCK and ROCK have distinct roles in the spatial reg-
ulation of MLC phosphorylation (Fig. 3 A). Control cells
(a–c) showed MLC phosphorylation in the center as well as
at the periphery (b), as shown previously (Matsumura et
al., 1998). Ratio imaging (c) exhibits a bimodal distribu-
tion of phosphorylated myosin (arrowhead at the anterior
and arrow at the rear). Inhibition of MLCK with BATI
greatly reduced MLC phosphorylation specifically at the
periphery, but not at the center of the cell (f, cell bound-
aries indicated by dashed lines). In contrast, ROCK-inhib-
ited cells retained MLC phosphorylation at the anterior re-
gion (h and i, arrowheads), whereas phosphorylation in the
center of cells was greatly diminished. Interestingly, ratio
imaging (i) revealed the enrichment of phosphorylated my-
osin at the tail (arrow). When both MLCK and ROCK
were blocked, cells showed no enrichment of MLC phos-
phorylation at either the cell center or periphery (l, arrow-
heads), verifying the notion that MLCK and ROCK are
the major MLC kinases in the cell. Ratio imaging revealed
the enrichment of phosphorylated myosin at thin, retrac-
tion fiberlike structures (l, arrow).
These alterations in spatial distributions of MLC phos-
phorylation appear to affect the assembly of adhesive struc-
tures and the actin cytoskeleton to a great extent (Fig. 3 B).
Control cells showed vinculin staining both in the leading
edge and in the center (b), which corresponded to the distri-
bution of phosphorylated MLC in these cells (a). MLCK-
inhibited cells (d–f) generated large membrane protrusions
around the cells (arrowheads). Concomitant with the spe-
cific loss of MLC phosphorylation at these protrusions (d,
Figure 2. Effects of the inhibition of MLCK and 
ROCK on cell migration paths, rates, turn angles, 
and migration distances. (A) Analyses of migration 
paths. Top left, control cells; top right, MLCK-
inhibited cells; bottom left, ROCK-inhibited cells; 
and bottom right, MLCK- and ROCK-inhibited cells. 
(B) Semicircular histograms showing the distributions 
of turn angles of trajectory (divided into 20  segments 
between 0  and 180 ). Left, MLCK-inhibited cells 
(blue); middle, ROCK-inhibited cells (red); and right, 
MLCK- and ROCK-inhibited cells (green). The 
histogram of control cells (black) is shown on the 
right side of each panel for comparison. (C) Left, cell 
migration rates; middle, total migration distance 
during a 60-min period; and right, directional 
persistence of cell migration. Data represent
mean   SD from trajectories of at least eight cells. 
**, P   0.01 as compared with control, t test. 
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cell boundaries indicated by dashed lines), vinculin staining
at this location (e, arrowheads) became much weaker than
the control. In contrast, focal adhesions (as well as stress fi-
bers) in the center of cells appeared intact (e and f).
ROCK inhibition produced very different effects (g–i).
Vinculin staining at the cell periphery (h, arrowhead) was re-
tained, whereas vinculin staining in the center was lost (h,
asterisk). Although stress fibers were disassembled, periph-
eral actin organization appeared largely unaffected (i, arrow-
head). When both MLCK and ROCK were inhibited (j–l),
stress fibers as well as peripheral actin filaments disappeared,
probably reflecting to the loss of MLC phosphorylation
at the entire region. Vinculin staining (k) was also lost
throughout the cytoplasm, though faint staining, reminis-
cent of focal complexes, was observed at the very edge of
membrane protrusions. This suggests that assembly of these
structures may not depend on MLC phosphorylation.
The analyses described above indicate that MLCK, but
not ROCK, is responsible for MLC phosphorylation at the
periphery. Because MLCK is a dedicated kinase that phos-
phorylates only MLC, MLC phosphorylation by MLCK is
likely to control membrane protrusions as well as the assem-
bly of strong vinculin-positive structures at the edge of
membrane protrusions. The presence of active MLCK at the
Figure 3. Effects of the MLCK and/or ROCK inhibitors on spatial regulation of MLC phosphorylation, as well as on the organization of 
vinculin and F-actin. (A) Ratio image analyses of MLC phosphorylation. Control (a–c), MLCK-inhibited (d–f), ROCK-inhibited (g–i), or MLCK- 
and ROCK-inhibited (j–l) cells were double stained with the antibodies against myosin heavy chain (myosin HC; a, d, g, and j) and phosphor-
ylated MLC (P-MLC; b, e, h, and k). Ratio images of phosphorylated MLC divided by total myosin (P-MLC/HC) are shown in c, f, i, and l. Note 
that the cell boundaries of MLCK-inhibited cells are outlined by dashed lines in f. (B) Immunofluorescence images of phosphorylated MLC, 
vinculin, and F-actin (stained by phalloidin). Control (a–c), MLCK-inhibited (d–f), ROCK-inhibited (g–i), or MLCK- and ROCK-inhibited (j–l) 
cells were triple-stained with antibodies against phosphorylated MLC (P-MLC; a, d, g, and j), vinculin (b, e, h, and k), and with fluorescent 
phalloidin (c, f, i, and l). Note that the cell boundaries of MLCK-inhibited cells are outlined by dashed lines in d. Bars, 20  m. 
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periphery is consistent with FRET analyses, which demon-
strated that active MLCK is localized at membrane ruffling
(Chew et al., 2002).
 
Changes in MLC phosphorylation are, at least in part, 
responsible for the alterations in cell migration and 
morphology induced by ROCK inhibition
 
ROCK has been reported to phosphorylate a variety of sub-
strates including MLC, MYPT, ERM proteins, and LIMK
(Riento and Ridley, 2003). To determine whether MLC
phosphorylation is involved in the ROCK-dependent alter-
ations in cell migration, we examined how expression of a
phosphomimetic mutant of MLC (replacing both Ser19 and
Thr18 with aspartic acid) modulates cell migration, as well
as the organization of actin and focal adhesions of ROCK-
inhibited cells. Gerbil fibroma cells were transfected with
GFP fusion constructs of the phosphomimetic mutant
(MLC-DD) or wild-type MLC (MLC-WT). Transfected
cells were then treated with the ROCK inhibitor, and ana-
lyzed by time-lapse, phase-contrast microscopy.
We found that expression of the phosphomimetic mutant
negated increased cell translocation caused by ROCK inhi-
bition. Fig. 4 A shows GFP fluorescence images for the iden-
tification of transfected cells (a and e), as well as phase-con-
trast images at 0 (b and f) and 60 min (c and g) and the
panels showing migration distances during these periods (d
and h). Cells expressing MLC-DD (a–d, arrowheads; see
also Video 5) exhibited little translocation even in the pres-
ence of the ROCK inhibitor, whereas other untransfected
cells showed increased migration. In contrast, cells trans-
fected with MLC-WT (e–g, arrowheads) migrated in a way
similar to untransfected cells, and frequently showed long
tails, a characteristic of ROCK-inhibited cells (e–h, arrow-
heads; see also Video 6). Analyses of migration tracks (Fig. 4
B) confirmed that cells expressing MLC-DD did not mi-
grate, whereas cells expressing MLC-WT migrated more
Figure 3 (continued from previous page). 
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straight and traveled long distances, the pattern of which is
indistinguishable from that of untransfected cells (compare
Fig. 4 B with Fig. 2 A). The migration rate (0.27 
 
 
 
 0.06
 
 
 
m/min) of MLC-DD–expressing cells was decreased to
55% of that (0.49 
 
 
 
 0.04 
 
 
 
m/min) of cells transfected with
MLC-WT, though the reduced rate is similar to that shown
by control cells in the absence of ROCK inhibitor (compare
Fig. 4 B with Fig. 2 C). The migration distance and direc-
tional persistence of MLC-DD–expressing cells were greatly
reduced to 1.01 
 
 
 
 0.65 
 
 
 
m and 0.11 
 
 
 
 0.04, respectively
(those values for MLC-WT–expressing cells were 19.5 
 
 
 
5.83 
 
 
 
m and 0.69 
 
 
 
 0.05, respectively).
As shown in Fig. 4 C, cells expressing MLC-DD re-
tained stress fibers (c) and focal adhesions (b) in the pres-
ence of the ROCK inhibitor. In addition, MLC-DD was
localized in stress fibers (a). In contrast, cells expressing
MLC-WT were similar to untransfected cells. MLC-WT
was diffusely present in the cytoplasm (d), and there was
no induction of focal adhesions (e) or stress fibers (f).
These analyses suggest that the changes in MLC phosphor-
ylation are, at least in part, responsible for the ROCK-
dependent alterations in cell migration and cell morphol-
ogy, though it is possible that changes in phosphorylation
of other ROCK substrates may also be involved in the al-
terations in cell motility.
 
ROCK inhibition does not induce Rac activation 
in gerbil fibroma cells
 
ROCK inhibition has been reported to activate Rac in Swiss
3T3 cells (Tsuji et al., 2002), and increases membrane ruffling
in HUVECs (Wojciak-Stothard and Ridley, 2003). Thus,
Rac activation may be a reason for the increased cell motility
of gerbil fibroma cells induced by ROCK inhibition. How-
ever, a pull-down assay using the GST-PAK-PBD domain re-
vealed that neither ROCK nor MLCK inhibition changed the
level of active Rac in our cells (Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200306172/DC1).
 
Inhibition of myosin phosphatase blocked cell migration
 
The inhibition of cell motility by MLC-DD expression sug-
gests that increased MLC phosphorylation and/or blockage
of turnover of MLC phosphorylation inhibit cell migration.
To test this idea, we blocked myosin phosphatase by micro-
injection of a function-inhibiting antibody against MYPT (5
mg/ml) as described previously (Totsukawa et al., 2000),
and examined its effects on cell migration, as well as on cel-
Figure 4. MLC-DD negated the increased cell 
translocation caused by ROCK-inhibition. (A) Cell 
migration of MLC-DD–expressing cell (a–d, arrow-
heads) or MLC-WT–expressing cell (e–h, arrowheads) 
in the presence of the ROCK inhibitor. a and e, GFP 
fluorescence images. Phase-contrast images were 
taken at 0 (b and f) and 60 min (c and g). d and h; 
net translocation during this period. Bar, 20  m. (B) 
Migration trajectories (red lines, MLC-WT–expressing 
cells; blue lines, MLC-DD–expressing cells), migra-
tion rates, migration distances, and directional 
persistence. Data represent mean   SD from trajec-
tories of at least eight transfected cells. **, P   0.01, 
t test. (C) Immunofluorescence images of MLC-DD–
expressing cells (a–c) and MLC-WT–expressing cells 
(d–f). a and d, GFP fluorescence; b and e, vinculin; 
c and f, phalloidin. Bar, 20  m. See also Videos 5 
and 6, available at http://www.jcb.org/cgi/content/
full/jcb.200306172/DC1. 
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lular morphology and membrane protrusions. As expected,
the inhibition of myosin phosphatase greatly increased MLC
phosphorylation of gerbil fibroma cells, resulting in thicker
stress fibers as well as larger focal adhesions (unpublished
data). A preimmune antibody (5 mg/ml) showed no effects
on MLC phosphorylation or the organization of the actin
cytoskeleton (unpublished data).
Time-lapse, phase-contrast microscopy was performed to
analyze effects on cell migration. Fig. 5 A shows the fluo-
rescent images of rhodamine-dextran for an injection
marker (a and e); the phase-contrast images captured at 30
(b and f) and 90 min (c and g) after injection, as well as the
panels showing migration distances during the 60-min pe-
riod (d and h). The cell injected with the preimmune-Ab
(a–d, indicated by arrowheads; Video 7) migrated as well
as other noninjected cells. In contrast, the cell injected
with MYPT-Ab (e–h, indicated by arrowheads; Video 8)
did not move. The analyses of migration tracks (Fig. 5 B)
also revealed that the function-inhibiting antibody blocked
 
cell migration, whereas the preimmune-Ab showed no sig-
nificant effect (compare Fig. 5 B with Fig. 2 A, top left).
The injection of MYPT-Ab significantly reduced the mi-
gration distances and directional persistence to 1.42 
 
 
 
0.23 
 
 
 
m (20%) and 0.08 
 
 
 
 0.01 (22%), respectively,
whereas the rate of migration appeared unchanged (Fig. 5
C). In contrast, cells injected with preimmune-Ab showed
the migration distance (7.00 
 
 
 
m 
 
  
 
3.43) and directional
persistence (0.35 
 
 
 
 0.15), similar to those of uninjected
cells (compare Fig. 5 C with Fig. 2 C).
 
MLCK, but not ROCK, is critical for the dynamic 
assembly of zyxin-containing adhesion structures 
at the leading edge
 
Cell migration requires new assembly of attachment sites.
Because the MLCK and ROCK inhibitors caused distinct
effects on the spatial organization of vinculin-containing
structures (Fig. 3 B) as well as motility (Fig. 1 and Fig. 2),
we analyzed how these inhibitors affected the dynamics of
adhesive structures. To this end, we used cells expressing
GFP-zyxin because zyxin is an excellent marker for the as-
sembly of focal complexes, as well as for mature focal adhe-
sions (Rottner et al., 2001). Gerbil fibroma cells were first
transfected with GFP-zyxin, treated with the inhibitors,
and then observed by time-lapse fluorescence microscopy.
Fig. 6 depicts representative images taken from the time-
lapse movies.
In control cells, the assembly of focal complexes and adhe-
sions is dynamic (Fig. 6 A, a; Video 9): zyxin-containing
structures were newly formed at the periphery of the leading
edge. These structures were highly transient (a, arrowheads),
and some of them matured into focal adhesions. As reported
previously (Smilenov et al., 1999), focal adhesions did not
change their positions during cell migration. As the cell
moved forward, focal adhesions were located inside the cell
and disappeared (most focal adhesions were disassembled
within 10 min; see Video 9).
Inhibition of MLCK blocked the formation and/or matu-
ration of zyxin-containing structures at the edge of mem-
brane protrusions (Fig. 6 A, b; Video 10). Although cells
produced membrane protrusions all around the cell, these
protrusions showed very weak signals of GFP-zyxin (b, ar-
rowheads). On the other hand, many focal adhesions were
observed inside the cell and were relatively stable. These ob-
servations suggest that MLCK is required for the assembly
and/or maturation of zyxin-containing adhesion structures
at the leading edge, but not for the assembly of mature focal
adhesions in the center.
In contrast, ROCK-inhibited cells (Fig. 6 A, c) assem-
bled highly dynamic zyxin-containing structures at the
leading edge (c, arrowheads; Video 11). However, these
structures did not mature into focal adhesions as the cell
moved forward. Instead, they quickly disassembled inside
the cell, indicating that ROCK activity in the center is es-
sential for the maturation into focal adhesions. When
both MLCK and ROCK were inhibited (Fig. 6 A, d;
Video 12), strong zyxin-positive structures were neither
formed at the leading edges nor inside cells. Instead, weak
zyxin-containing structures were present as transient small
foci all over the cells.
Figure 5. Inhibition of myosin phosphatase blocks cell migration. 
(A) Cell migration of preimmune-Ab–injected cell (a–d) and MYPT-
Ab–injected cell (e–h). Arrowheads denote injected cells. a and e, 
injection marker. Phase-contrast images were taken at 30 min (b and f) 
and 90 min (c and g) after microinjection. d and h, net translocation. 
Bar, 20  m. (B) Migration paths (red lines for preimmune-Ab and 
blue lines for MYPT-Ab). (C) Migration rates, migration distances, and 
directional persistence. Data represent mean   SD from trajectories of 
at least eight injected cells. **, P   0.01, t test. See also Videos 7 and 8, 
available at http://www.jcb.org/cgi/content/full/jcb.200306172/DC1.Roles of MLCK and ROCK in cell migration | Totsukawa et al. 435
Figure 6. Distinct roles of MLCK, ROCK, and myosin phosphatase in the dynamics of zyxin-containing structures. (A) Time-lapse fluorescence 
microscopy to examine effects of MLCK and ROCK inhibition. (a) control cells; (b) MLCK-inhibited cells; (c) ROCK-inhibited cells; (d) MLCK- 
and ROCK-inhibited cells. Times shown in min. (B) Effect of the inhibition of myosin phosphatase. Times after microinjection shown in min. 
Arrowheads indicate GFP-zyxin–containing structures. Bars, 20  m. See also Videos 9–13, available at http://www.jcb.org/cgi/content/full/
jcb.200306172/DC1.436 The Journal of Cell Biology | Volume 164, Number 3, 2004
Inhibition of myosin phosphatase blocked the turnover 
of focal adhesion assembly
Finally, we examined how the increase in MLC phosphory-
lation alters the dynamics of focal adhesion assembly. The
function-inhibiting antibody was injected into cells express-
ing GFP-zyxin, and the dynamics of focal adhesion assembly
was monitored as described in the previous section.
Injection of the antibody blocked the disassembly of fo-
cal adhesions (Fig. 6 B). Although the injected cell ini-
tially showed moderate contraction, focal adhesions became
longer and larger, and were not disassembled within a 60-
min time window (Fig. 6 B, arrowheads; Video 13). In con-
trast, most focal adhesions of cells injected with the preim-
mune-Ab disassembled within 10 min (unpublished data).
These results indicate that blockage of myosin phosphatase
inhibits turnover of focal adhesions, resulting in an inhibi-
tion of cell migration. During the initial contraction, the in-
jected cells showed no typical membrane protrusions or ruf-
fling. The contraction eventually stopped  20–30 min after
injection, and then the antibody-injected cell exhibited atyp-
ical membrane protrusions (i.e., a burst of short pseudopod-
like protrusions; see Video 13). These protrusions quickly
retracted, probably due to the high activity of myosin II-
based contractility, and no stable zyxin-containing adhesions
were established at the protrusions.
Discussion
Localization-specific roles of MLC phosphorylation 
in cell migration
Our results have elucidated localization-specific roles of my-
osin II in the regulation of membrane protrusions, as well as
in the dynamics of adhesive structures.
Cell periphery and leading edge
We propose that myosin II phosphorylated at the periphery
has two functions. First, phosphorylated myosin II at this lo-
cation restricts membrane protrusions by counteracting pro-
trusive activity powered by actin polymerization. This no-
tion is supported by the observation that the loss of MLC
phosphorylation at the periphery of MLCK-inhibited cells
resulted in the generation of membrane protrusions all
around the cell (Fig. 1 and Fig. 3). It is also supported by the
reciprocal experiment: increased MLC phosphorylation as a
result of blocking myosin phosphatase inhibited membrane
ruffling (Fig. 5). This role for myosin II is also consistent
with a previous report showing that a Dictyostelium mutant
deficient in myosin II extends membrane protrusions in
multiple directions (Wessels and Soll, 1990).
Second, phosphorylated myosin II at the periphery is nec-
essary for the assembly and/or maturation of vinculin- and
zyxin-containing adhesive structures at the leading edge of
motile cells. Although MLCK-inhibited cells formed tiny
focal contact-like structures at the very ends of protrusions
(Fig. 3 B, e; Fig. 6 A, b), these structures were not assembled
or matured into larger adhesions. In addition, the protru-
sions of MLCK-inhibited cells retracted more frequently
than did those of control cells (Fig. 1 D, compare Video 1
with Video 2). These observations suggest that the assembly
of and/or maturation into the large vinculin- and zyxin-con-
taining structures provide adhesive sites, thereby stabilizing
the membrane protrusion at the anterior part of motile cells.
The instability of the protrusions of MLCK-inhibited cells,
as well as their occurrence at multiple locations, explains
why these cells showed more frequent turns and less efficient
cell migration. Though phosphorylated myosin may directly
affect the formation of membrane protrusions or adhesions,
such effects could also be indirect. For example, MLC phos-
phorylation may modulate “inside-out” signaling, affecting
integrin–ECM interactions, which in turn leads to the alter-
ations in cell protrusions and cell migration.
Cell center
MLC phosphorylation at the center is necessary for the mat-
uration of peripheral adhesive structures into focal adhe-
sions. Vinculin- and zyxin-containing structures assembled
at the periphery of ROCK-inhibited cells quickly disap-
peared without maturating into focal adhesions when they
entered into the center (Fig. 6 A, c). Mature focal adhesions
are relatively stable structures and probably function as a
“brake” on the cell migration machinery. The lack of the
brake in ROCK-inhibited cells could explain why these cells
moved faster and more straight (Fig. 2), though it is possible
that changes in other ROCK substrates may contribute to
the alterations in cell migration.
MLCK and ROCK differentially regulate turnover rates 
of MLC phosphorylation
We suggest that MLCK and ROCK could differentially reg-
ulate the dynamics of adhesive structures in these two loca-
tions by regulating turnover rates of MLC phosphorylation.
Although both MLCK and ROCK can phosphorylate
MLC, the specific activity of MLCK is one or two orders
higher than that of ROCK (Amano et al., 1996; Feng et al.,
1999). Both MLCK and myosin phosphatase are localized
in membrane ruffling (Chew et al., 2002; Smith et al., 2003;
unpublished data), and such colocalization at the leading
edge would result in a high turnover rate of MLC phosphor-
ylation. Because the assembly of vinculin- and zyxin-con-
taining adhesive structures at the leading edge depends on
MLC phosphorylation, the high turnover rate would allow
dynamic assembly and disassembly of these structures at the
leading edge. On the other hand, in the center of cells
ROCK may achieve a slower phosphorylation of MLC, and
via the phosphorylation of MYPT, inhibit myosin phos-
phatase. This would result in a very slow turnover rate of
MLC phosphorylation in the cell center, which could reflect
the relatively stable nature of focal adhesions.
Mechanism for the regulation of anterior MLC 
phosphorylation during directional migration
The generation of multiple membrane protrusions in
MLCK-inhibited cells suggests that if myosin II is inacti-
vated, actin polymerization and resultant membrane protru-
sions could occur anywhere at the periphery without exter-
nal signals. Thus, there must be a mechanism that precisely
controls MLC phosphorylation at the cell periphery when
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leading edge is probably complex because the leading edge
should have a low MLC phosphorylation state for mem-
brane protrusions, and at the same time a high MLC phos-
phorylation state for the assembly of adhesive structures. Fig.
7 depicts one possible model. We hypothesize that myosin
phosphatase is activated at the leading edge of motile cells
(Fig. 7, A and B). This could reflect the activation of Rac at
the leading edge (Kraynov et al., 2000; Gardiner et al.,
2002). Active Rac has been shown to down-regulate Rho ac-
tivity (Sander et al., 1999), possibly via the activation of
p190RhoGAP, a Rho-GTPase activating protein, which is
localized at membrane ruffling (Arthur and Burridge, 2001;
Nimnual et al., 2003). This would lead to the inactivation of
ROCK, thereby negating inhibitory effects on myosin phos-
phatase, i.e., an apparent activation.
How could the leading edge have both high and low MLC
phosphorylation states? One possibility is that MLCK activ-
ity could fluctuate. In a low activity state (Fig. 7 A), MLC
phosphorylation is reduced, thus allowing a membrane pro-
trusion. In a high activity state (Fig. 7 B), MLC phosphory-
lation is transiently increased, assembling new and transient
adhesions at the periphery. High MLC phosphorylation
may also act as a retracting force. The high myosin phos-
phatase activity, together with changes in MLCK activity,
would promote turnover of MLC phosphorylation at the
leading edge, causing cycles of protrusions, adhesions, and
retraction for cell migration. If myosin phosphatase is inacti-
vated (Fig. 7 C), then MLC phosphorylation is increased at
the periphery, restricting membrane protrusions. At the
same time, turnover of phosphorylation is reduced, assem-
bling stable adhesions and blocking cell migration. This sit-
uation was experimentally realized by blocking myosin
phosphatase with the function-inhibiting antibody (Fig. 5
and Fig. 6 B).
Other upstream molecules are likely to participate in the
regulation of myosin phosphatase and MLCK during cell
migration. Active Rac, for example, may inhibit MLCK at
the leading edge because Rac-activated protein kinase (PAK)
has been reported to inhibit MLCK by phosphorylating
MLCK (Sanders et al., 1999). Other possible regulatory
mechanisms for MLCK include inhibition by PKA (Lamb et
al., 1988) and activation by MAPK (Klemke et al., 1997).
Myosin phosphatase could be regulated by phosphorylation
of MYPT with a number of kinases including ROCK, PAK,
ZIP-like kinase, myotonic dystrophy protein kinase, and
integrin-linked kinase. Obviously, the regulatory mecha-
nism(s) could be complex, and the activities of MLCK and
myosin phosphatase probably vary depending on cell types.
Such variations may be one of the reasons for cell type–spe-
cific responses to the ROCK inhibitors in cell migration.
For example, the ROCK inhibitor Y-27632 has been shown
to either promote or inhibit cell migration (Itoh et al., 1999;
Nobes and Hall, 1999; Wojciak-Stothard and Ridley,
2003). Most recently, it has been reported that the inhibi-
tion of ROCK induced multiple membrane protrusions in
leukocytes (Worthylake and Burridge, 2003), which is op-
posite to the results shown here with gerbil fibroma cells. It
is possible that MLCK activity may be lower in leukocytes,
and the ROCK inhibitor could eliminate MLC phosphory-
lation even at the anterior region. If so, this would result in
the generation of multiple protrusions and less efficient cell
migration. Future analyses should be directed toward eluci-
dating the upstream signaling cascades that alter the activi-
ties of MLCK, ROCK, and myosin phosphatase in different
types of cells under specific conditions. It is critical to deter-
mine how such alterations result in localization-specific
changes in the phosphorylation of MLC, and how spatial al-
terations in phosphorylation affect cell migration. Such anal-
yses should help us understand how cell motility is regulated
in normal and pathological conditions including embryo-
genesis, tissue repair, and cancer metastasis.
Materials and methods
Reagents, proteins, and antibodies
Antibodies were used as follows: a pAb against MYPT (Totsukawa et al.,
2000); an mAb against Ser 19-phosphorylated MLC (Sakurada et al.,
1998); a pAb against Ser19-phosphorylated MLC (Matsumura et al., 1998);
a pAb against platelet myosin heavy chain (a gift from Drs. J. Sellers and R.
Adelstein, National Institutes of Health, Bethesda, MD); an mAb against
smooth/nonmuscle myosin heavy chain (Immunotech); a monoclonal anti-
Rac1 antibody (BD Biosciences); and a monoclonal anti-vinculin antibody
(Sigma-Aldrich).
Y-27632, a specific inhibitor of ROCK, was provided by Yoshitomi
Pharmaceutical Industries. A mammalian expression vector for EGFP-zyxin
(pEGFP-N1-zyxin) was provided by Drs J. Wehland (Gesellschaft für Bio-
technologische Forschung, Braunschweig, Germany) and J.V. Small (Aus-
trian Academy of Sciences, Vienna, Austria); mammalian expression vec-
tors for pEGFP-N1-MLC-WT and pEGFP-N1-MLC-DD were provided by
Dr. K. Kelly (National Cancer Institute, Bethesda, MD; Ward et al., 2002);
and a bacterial expression vector for GST-PBD was provided by Dr.
R.A. Cerione (Cornell University, Ithaca, NY; Bagrodia et al., 1998). Rho-
damine-dextran and coumarin-conjugated phalloidin was purchased from
Molecular Probes, Inc. and Sigma-Aldrich, respectively.
Membrane-permeable MLCK inhibitor peptide (BATI) was constructed
based on the TAT vector and the pseudosubstrate sequence of smooth/
nonmuscle MLCK (Wu et al., 2003). The MLCK sequence KKYMARRK-
WQKAGHAV (Foster et al., 1990) was fused to the COOH terminus of the
TAT sequence YGRKKRRQRRRPPQ (Schwarze et al., 1999); biotin was at-
tached to the NH2 terminus to check membrane permeability. The IC50 for
this inhibitor (measured at 1 mM ATP) was 0.4  M for both smooth muscle
and skeletal muscle MLCK (Wu et al., 2003). BATI shows  100% transfec-
Figure 7. Model for the role of myosin II phosphorylation at the 
anterior region of motile cells. (A) low MLC phosphorylation state at 
the leading edge of a motile cell; (B) high MLC phosphorylation state 
at the leading edge of a motile cell; (C) high MLC phosphorylation 
state at the periphery of a stationary cell. Turnover rates of MLC 
phosphorylation are high in A and B, but low in C. See Discussion 
for details.438 The Journal of Cell Biology | Volume 164, Number 3, 2004
tion efficiency and is readily transported inside cells within 15 min. BATI
showed no inhibition with ROCK. As a control, we used the TAT vector se-
quence without the pseudosubstrate sequence, which had no inhibitory ef-
fect on MLCK activity at 1 mM ATP.
Time-lapse recording
Gerbil fibroma cells (CCL146, American Type Culture Collection) were
maintained in DME containing 10% FCS. For time-lapse observation, cells
on a coverslip were transferred into Hepes-buffered DME (Invitrogen) con-
taining 10% FCS, and were overlayed with mineral oil to prevent evapora-
tion. Cells were then placed in a temperature control incubator (MS200D,
Narishige) to maintain the temperature at 37 C, and were observed under
a microscope (TE300; Nikon) with a 20  Plan Fluor phase-contrast (NA
0.45) objective lens. Time-lapse images were taken by a CCD camera
(CoolSNAP fx; Roper Scientific) with IPLab image analysis software (Scana-
lytics). To observe the effects of MLCK or ROCK inhibition, cells were
treated with 20  M BATI and/or 10  M Y27632 for 30 min before time-
lapse recording. Drugs were present during the course of imaging. For the
observation of focal adhesion dynamics, cells were microinjected with the
expression construct of pEGFP-N1-zyxin. EGFP-zyxin–expressing cells
were then processed for time-lapse observation as described above, except
that a 40  Plan Fluor phase-contrast lens (NA 0.6) was used. Cells were
also transfected with pEGFP-MLC-WT or pEGFP-MLC-DD using Lipo-
fectAMINE™ Plus reagent (Invitrogen).
Analysis of cell migration
Motility parameters including rates of migration, migration paths, dis-
tances, directional persistence, and kymographs were obtained from time-
lapse movies. Images were recorded at 2-min intervals because gerbil fi-
broma cells seldom changed direction during this time window. To track
migration paths, the outlines of individual cells were manually traced for
each frame, and the geographical centers were recorded using IPLab im-
age analysis software. The migration paths were expressed as a graph using
the Microsoft Excel program. The migration trajectories of at least eight
cells were analyzed for each condition. The rates of cell migration were
determined by averaging  30 segments of migration paths. Migration dis-
tances were determined as a net translocation moved during a 60-min pe-
riod. To visualize the directionality of cell migration, the turn angles made
by two consecutive segments of the trajectory was measured, and the dis-
tributions of absolute turn angles were shown by a semicircular histogram.
Directional persistence (D/T ratio) was calculated as a ratio of the direct
distance during a 60-min period (D) and the total length of migration path
(T). Cell spreading was determined by measuring cell area, and was ex-
pressed as a relative value by normalizing the average area of control cells
as 1.0. Cell polarity was determined by measuring a ratio of major and mi-
nor axes of the cell. Kymograph analysis of membrane protrusions was
performed using IPLab software.
Immunofluorescence
Cells grown on coverslips were fixed with 3.7% formaldehyde in PBS at
RT for 10 min, and were permeabilized with acetone at  20 C for 5 min.
Primary antibodies used were polyclonal anti-myosin heavy chain (1/500),
monoclonal anti-phospho-MLC (1/50), polyclonal anti-phospho-MLC
(1/25), or anti-vinculin (1/400). Secondary antibodies used were FITC anti–
mouse IgG and TRITC anti–rabbit IgG (1/100, Jackson ImmunoResearch
Laboratories). Coumarin-phalloidin was used for F-actin staining. Images
were acquired using a microscope (TE300; Nikon) with a 60  (Plan Apo,
NA 1.4) phase-contrast objective lens, a CoolSNAP fx CCD camera, and
IPLab software. Images were processed using Adobe Photoshop
® 6.0. For
ratio imaging in Fig. 3, a grayscale image of P-MLC staining (with the mAb)
was divided by a corresponding image of total myosin (stained with the
pAb to myosin heavy chain) using IPLab software. Essentially, the same re-
sults were obtained by ratio imaging using the mAb against myosin heavy
chain and the pAb against P-MLC.
Online supplemental material
Fig. S1 shows that the TAT control peptide has no effect on cell morphol-
ogy and migration. Fig. S2 shows that Rac is not activated by Y27632 or
BATI treatment. The corresponding QuickTime movie files of live cells are
organized as follows: Videos 1–4 for Fig. 1 A; Videos 5 and 6 for Fig. 4 A;
Videos 7 and 8 for Fig. 5 A; Videos 9–12 for Fig. 6 A; and Video 13 for Fig.
6 B. Supplemental material available online at http://www.jcb.org/cgi/
content/full/jcb.200306172/DC1.
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